Literature DB >> 19824105

Adult celiac disease with acetylcholine receptor antibody positive myasthenia gravis.

Hugh J Freeman1, Helen R Gillett, Peter M Gillett, Joel Oger.   

Abstract

Celiac disease has been associated with some autoimmune disorders. A 40-year-old competitive strongman with celiac disease responded to a gluten-free diet, but developed profound and generalized motor weakness with acetylcholine receptor antibody positive myasthenia gravis, a disorder reported to occur in about 1 in 5000. This possible relationship between myasthenia gravis and celiac disease was further explored in serological studies. Frozen stored serum samples from 23 acetylcholine receptor antibody positive myasthenia gravis patients with no intestinal symptoms were used to screen for celiac disease. Both endomysial and tissue transglutaminase antibodies were examined. One of 23 (or, about 4.3%) was positive for both IgA-endomysial and IgA tissue transglutaminase antibodies. Endoscopic studies subsequently showed duodenal mucosal scalloping and biopsies confirmed the histopathological changes of celiac disease. Celiac disease and myasthenia gravis may occur together more often than is currently appreciated. The presence of motor weakness in celiac disease may be a clue to occult myasthenia gravis, even in the absence of intestinal symptoms.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19824105      PMCID: PMC2761549          DOI: 10.3748/wjg.15.4741

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  21 in total

1.  Inclusion body myositis associated with celiac sprue and idiopathic thrombocytopenic purpura.

Authors:  Sandra F Williams; Betty A Mincey; Kenneth T Calamia
Journal:  South Med J       Date:  2003-07       Impact factor: 0.954

2.  Identification of tissue transglutaminase as the autoantigen of celiac disease.

Authors:  W Dieterich; T Ehnis; M Bauer; P Donner; U Volta; E O Riecken; D Schuppan
Journal:  Nat Med       Date:  1997-07       Impact factor: 53.440

3.  Putative role of antireticulin antibody in antiacetylcholine-receptor-antibody-negative myasthenia gravis.

Authors:  T U Hoogenraad; F H Gmelig Meyling
Journal:  Arch Neurol       Date:  1987-05

4.  Letter: Gluten and myasthenia gravis.

Authors:  J H Edwards
Journal:  Lancet       Date:  1975-07-05       Impact factor: 79.321

Review 5.  Studies in myasthenia gravis: review of a twenty-year experience in over 1200 patients.

Authors:  K E Osserman; G Genkins
Journal:  Mt Sinai J Med       Date:  1971 Nov-Dec

6.  Neuromyelitis optica in patients with myasthenia gravis who underwent thymectomy.

Authors:  Ilya Kister; Sandeep Gulati; Cavit Boz; Roberto Bergamaschi; Giovanni Piccolo; Guiseppe Piccolo; Joel Oger; Michael L Swerdlow
Journal:  Arch Neurol       Date:  2006-06

7.  [Regressive myopathy with myasthenic syndrome in idiopathic gluten enteropathy].

Authors:  H J Gundlach; K Ernst
Journal:  Psychiatr Neurol Med Psychol (Leipz)       Date:  1975-04

8.  High prevalence of celiac disease in patients with type 1 diabetes detected by antibodies to endomysium and tissue transglutaminase.

Authors:  P M Gillett; H R Gillett; D M Israel; D L Metzger; L Stewart; J P Chanoine; H J Freeman
Journal:  Can J Gastroenterol       Date:  2001-05       Impact factor: 3.522

9.  Co-occurrence of multiple sclerosis and myasthenia gravis in British Columbia.

Authors:  C M Isbister; P J Mackenzie; D Anderson; N K Wade; J Oger
Journal:  Mult Scler       Date:  2003-12       Impact factor: 6.312

10.  Acetylcholine receptor antibodies in myasthenia gravis: use of a qualitative assay for diagnostic purposes.

Authors:  J Oger; R Kaufman; K Berry
Journal:  Can J Neurol Sci       Date:  1987-08       Impact factor: 2.104

View more
  4 in total

1.  Recent advances in celiac disease.

Authors:  Hugh James Freeman; Angeli Chopra; Michael Tom Clandinin; Alan Br Thomson
Journal:  World J Gastroenterol       Date:  2011-05-14       Impact factor: 5.742

2.  Five-Month Trial of Whole-Food Plant-Based Diet in a Patient With Coexisting Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome.

Authors:  Peter Kim; Matthew Arnold; Jasmine Gunti
Journal:  Am J Lifestyle Med       Date:  2021-02-16

3.  Celiac disease and risk of myasthenia gravis - nationwide population-based study.

Authors:  Sujata P Thawani; Thomas H Brannagan; Benjamin Lebwohl; Peter H R Green; Jonas F Ludvigsson
Journal:  BMC Neurol       Date:  2018-03-12       Impact factor: 2.474

4.  Screening of Altered Metabolites and Metabolic Pathways in Celiac Disease Using NMR Spectroscopy.

Authors:  Ensieh Khalkhal; Mostafa Rezaei-Tavirani; Fariba Fathi; B Fatemeh Nobakht M Gh; Amir Taherkhani; Mohammad Rostami-Nejad; Nastaran Asri; Mohammad Hossain Haidari
Journal:  Biomed Res Int       Date:  2021-11-15       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.